It is possible, even if it has never been proved, that BRCA2 mutation carriers harbor more pre-malignant estrogen receptor-positive lesions and that repeated pregnancies might increase the risk of developing breast cancer [13]. This evidence concerns the gene BRCA2 and breast carcinoma.